@article{3fd9398a44f84add83cfce6c4e7d221a,
title = "Estimating long-term multivariate progression from short-term data",
abstract = "Motivation Diseases that progress slowly are often studied by observing cohorts at different stages of disease for short periods of time. The Alzheimer's Disease Neuroimaging Initiative (ADNI) follows elders with various degrees of cognitive impairment, from normal to impaired. The study includes a rich panel of novel cognitive tests, biomarkers, and brain images collected every 6 months for as long as 6 years. The relative timing of the observations with respect to disease pathology is unknown. We propose a general semiparametric model and iterative estimation procedure to estimate simultaneously the pathological timing and long-term growth curves. The resulting estimates of long-term progression are fine-tuned using cognitive trajectories derived from the long-term {"}Personnes Ag{\'e}es Quid{"} study.Results We demonstrate with simulations that the method can recover long-term disease trends from short-term observations. The method also estimates temporal ordering of individuals with respect to disease pathology, providing subject-specific prognostic estimates of the time until onset of symptoms. When the method is applied to ADNI data, the estimated growth curves are in general agreement with prevailing theories of the Alzheimer's disease cascade. Other data sets with common outcome measures can be combined using the proposed algorithm.Availability Software to fit the model and reproduce results with the statistical software R is available as the grace package. ADNI data can be downloaded from the Laboratory of NeuroImaging.",
keywords = "Growth curves, Multiple outcomes, Progression curves, Self-modeling regression, Semiparametric regression",
author = "Donohue, {Michael C.} and H{\'e}l{\`e}ne Jacqmin-Gadda and {Le Goff}, M{\'e}lanie and Thomas, {Ronald G.} and Rema Raman and Gamst, {Anthony C.} and Beckett, {Laurel A.} and Jack, {Clifford R.} and Weiner, {Michael W.} and Dartigues, {Jean Fran{\c c}ois} and Aisen, {Paul S.}",
note = "Funding Information: We acknowledge the invaluable contributions of our PAQUID and ADNI collaborators, co-investigators, volunteers, and their families. This work was support by a grant ( 1KL2RR031978 ) from the National Institutes of Health (NIH)-funded University of California , San Diego Clinical and Translation Research Institute ( 1UL1RR031980 ). Data collection and sharing for this project was funded by ADNI ( U01 AG024904 ). ADNI is funded by the National Institute on Aging , the National Institute of Biomedical Imaging and Bioengineering , and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC; Johnson & Johnson Pharmaceutical Research & Development LLC; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private-sector contributions are facilitated by the Foundation for the National Institutes of Health ( www.fnih.org ). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. The Laboratory for Neuroimaging at the University of Southern California disseminates ADNI data. This research was also supported by NIH grants P30 AG010129 and K01 AG030514 . Novartis and IPSEN laboratories , and Conseil Regional d'Aquitaine fund PAQUID. Publisher Copyright: {\textcopyright} 2014 The Alzheimer's Association.",
year = "2014",
month = oct,
day = "1",
doi = "10.1016/j.jalz.2013.10.003",
language = "English (US)",
volume = "10",
pages = "S400--S410",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "5",
}